Endoways Overview
EndoWays has developed a robotic microcatheter with advanced self-propulsion capabilities for navigation through tortuous blood vessels. The EndoWays microcatheter is designed to provide the interventional radiologist with a superior ability to cross tortuous anatomy, simplifying complex procedures, shortening overall procedure time, and minimizing radiation exposure to the patient and medical staff.
Cumulative Funding Raised Over Time ($)
$750KMar 2018
Latest News
growth-positive
Robotic catheter maker EndoWays acquired by Ascendum
Israeli company EndoWays, which developed a Robotic-assisted microcatheter, has been acquired by Hong Kong-based investment platform Ascendum. The acquisition will help EndoWays accelerate its clinical and commercial development, particularly in China. The technology developed by EndoWays allows efficient navigation through blood vessels without excessive radiation exposure. The acquisition amount was not disclosed, but industry estimates suggest it is in the $10 million range. EndoWays will relocate to a new headquarters in Caesarea. The companys founder, Noam Shamay, will serve as the chief technology officer post-acquisition. The deal provides EndoWays with access to Ascendums experience and network, aiding its growth in China.
Acquisition
growth-positive
MEDX Xelerator broadens international collaboration
Israeli medical-device incubator MEDX Xelerator is collaborating with innovation hubs in the EU and the US to advance medical technologies. In the EU, MEDX Xelerator will collaborate with Health Hub Vienna (HHV), while in the US, it will collaborate with Parvizi Surgical Innovation (PSI). MEDX Xelerator has also launched collaboration with the University of Navarra (UN) in Spain. Through these collaborations, MEDX Xelerator aims to facilitate exchange in fields essential to innovation infrastructure and leverage their networks of strategic partners, hospitals, and universities. The collaborations are part of MEDX Xelerators proactive strategy to address significant unmet medical needs.
Partners
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $750K |
| Last funding | $750K |
| Stage | Acquired |
| Rounds | 1 |
| Investors | 2 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | www.endoways.com |
Locations
Ariel Sharon Boulevard 8, Or Yehuda, Israel
Photos & Videos
1 item(s)
Endoways Business
Business models
B2B
Product stage
R&D
Employees
1-10
Sector
Health Tech & Life SciencesMedical DevicesMedical MonitorsTarget Customer
Healthcare & Life SciencesHealthcareProvidersCore Technology
Machinery & RoboticsTags (10)
surgeryclinicshospitalsmedical-technologiessurgeonscatheterssurgical-instrumentsradiologyroboticsneurovascularGeographic Markets
ChinaGlobalEndoways Financials
$750K
Total funding
Undisclosed
Capital raised
$750K
Last funding
Acquired
Funding stage
1
Total rounds
2
Investors
Cumulative Funding Raised Over Time ($)
$750KMar 2018
Private Equity Funding
Seed
Mar 2018
$750K
Israel Innovation Authority, MEDX Xelerator
Public Offering / Exit
MNAEvent
Feb 2021
Undisclosed
Endoways Lifecycle
Cumulative Funding Raised Over Time
$750KMar 2018
All Events
Seed
Mar 2018
$750K
Israel Innovation Authority, MEDX Xelerator
MNAEvent
Feb 2021
Undisclosed
Endoways News
2 articles
growth-positive
Robotic catheter maker EndoWays acquired by Ascendum
Israeli company EndoWays, which developed a Robotic-assisted microcatheter, has been acquired by Hong Kong-based investment platform Ascendum. The acquisition will help EndoWays accelerate its clinical and commercial development, particularly in China. The technology developed by EndoWays allows efficient navigation through blood vessels without excessive radiation exposure. The acquisition amount was not disclosed, but industry estimates suggest it is in the $10 million range. EndoWays will relocate to a new headquarters in Caesarea. The companys founder, Noam Shamay, will serve as the chief technology officer post-acquisition. The deal provides EndoWays with access to Ascendums experience and network, aiding its growth in China.
Acquisition
growth-positive
MEDX Xelerator broadens international collaboration
Israeli medical-device incubator MEDX Xelerator is collaborating with innovation hubs in the EU and the US to advance medical technologies. In the EU, MEDX Xelerator will collaborate with Health Hub Vienna (HHV), while in the US, it will collaborate with Parvizi Surgical Innovation (PSI). MEDX Xelerator has also launched collaboration with the University of Navarra (UN) in Spain. Through these collaborations, MEDX Xelerator aims to facilitate exchange in fields essential to innovation infrastructure and leverage their networks of strategic partners, hospitals, and universities. The collaborations are part of MEDX Xelerators proactive strategy to address significant unmet medical needs.
Partners
Endoways Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 2 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 7 classification IDs that could be used for matching.
Endoways Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 98/100 |
| Missing | markets |
| BI Verification | Jenny Sotnik-Talisman |
| Registrar ID | 515798114 |
| Crunchbase | endoways |
| Phone | +972747049582 |
| Creator | Jenny Sotnik-Talisman |
| Creator email | genys30@yahoo.com |
| Last updater | Yotam Maman |
| Updater email | yotamm1988@gmail.com |
| Last update | 2021-02-16T00:00:00.000Z |
| Created | 2018-03-19T00:00:00.000Z |
| Claimed | Yes |
| Status detail | Acquired by Ascendum Capital on Feb, 2021 |